OIG report lists HHS’ top ten challenges

data, patient, medical records, health data, healthcare data

A current report in the HHS Office of Inspector General details the very best 10 management and gratifaction challenges facing the department.

The identified topics have been in various HHS programs. Because the 48-page report reads, the department “should be conscious of those challenges and possibilities to deal with them because it undertakes its efforts to reimagine HHS included in the federal government’s comprehensive intend to reform government.”

Listed here are the very best issues, based on the report:


  • Making certain program integrity in Medicare. In fiscal year 2016, Medicare covered 56.8 million lives and spent as many as $679 billion. This expenses are only likely to increase. To enhance this program, HHS must reduce improper payments, combat fraud, build up prudent payment policies and implement healthcare reforms and health IT.
  • Making certain program integrity in State medicaid programs. Throughout the same fiscal year, combined federal and condition State medicaid programs spending hit $574 billion. Nearly 69 million everyone was enrolled. The primary facets of this concern include creating compliance with fiscal controls, utilizing fraud prevention tools and improving overall national State medicaid programs data.
  • Curbing the opioid epidemic. The CDC discovered that in 2015, greater than 33,000 individuals died from overdoses involving opioids. OIG encourages HHS to deal with myriad issues, such as the inappropriate prescribing of opioids, diversion of prescription opioids and fraud by providers for treating opioid abuse disorder. Furthermore, the report urges the department to take particular notice at insufficient patient use of treatment and any susipicious activity regarding grant funds.
  • Improving take care of vulnerable populations. Although it appears broad, the report breaks this concern lower into four groups. The very first two include reducing substandard elderly care care and decreasing problems in hospice care. OIG also believes HHS should make an effort to mitigate risks home based-based services and be sure use of safe services for kids.
  • Making certain integrity in managed care along with other programs delivered through private insurers. The main aspects of this are combating fraud and abuse by providers billing managed care plans, guaranteeing compliance with managed care and Medicare Medicare Part D sponsors and overseeing the insurance marketplaces.
  • Improving financial and administrative management and reducing improper payments. Addressing weaknesses in financial management systems, reducing improper payments and applying digital Accountability and Transparency Act are what OIG suggests HHS do in order to overcome this kind of issue.
  • Protecting the integrity of public Health insurance and Human Services grants. HHS awarded greater than $100 billion in grants (excluding State medicaid programs) in fiscal year 2016. To make sure ongoing success within this realm, HHS should make certain grants are correctly managed inside the department and manage program integrity and financial capacity in the grantee level.
  • Making certain the security of food, drugs and medical devices. Another broad challenge, this time earns the Food and drug administration. The company should monitor food facilities, implement the twenty-first century Cures Act and oversee the drug and medical device logistics.
  • Making certain program integrity and quality in programs serving American Indian and Alaska Native populations. HHS administered 45 percent of federal funds (as many as $7 billion) that provide American Indian and Alaska Native communities. Additionally to combating any susipicious activity regarding funds, OIG recommends HHS improve the caliber of take care of these populations.
  • Protecting HHS data, systems and beneficiaries from cybersecurity threats. As cybersecurity turns into a growing issue, it’s crucial that HHS keep its information safe. Another facet of this concern includes fostering a culture of cybersecurity at HHS with its partners and stakeholders.

Photo: nevarpp, Getty Images

First Digital Camera for Opioid Withdrawal Therapy Approved by Food and drug administration

The Food and drug administration has provided a regulatory eco-friendly light towards the first device that reduces opioid withdrawal signs and symptoms. The NSS-2 Bridge from Innovative Health Solutions, a Versailles, Indiana firm, is stuck towards the skin behind the ear and depends on four electrodes which are attached round the ear. The electrodes are utilized to deliver electric energy to some occipital and cranial nerves (V, VII, IX, and X), hopefully helping addicts to prevent agitation, insomnia, along with other signs and symptoms of kicking opioids. Exactly the same device was authorized by the Food and drug administration 3 years ago to be used in acupuncture and also the current approval went under the de novo review process meant for distinctively new low to moderate risk technologies.

The Food and drug administration based its decision on the study involving 73 patients which were experiencing physical signs and symptoms of withdrawal. Before while using NSS-2 Bridge, the topics had an average clinical opiate withdrawal scale (COWS) score of 20.1 (the greater, the more serious the signs and symptoms). While using device, the topics had a decrease in the COWS score by a minimum of 31% within 30 minutes of therapy activation. Furthermore, 64 from the 73 patients switched to medication aided therapy after 5 days of utilizing the NSS-2 Bridge.

The unit needs a prescription and isn’t supposed to have been utilized by patients using pacemakers or that suffer from hemophilia or skin psoriasis.

Product page: NSS-2 BRIDGE…

Via: FDA…


At Medgadget, we set of the most recent medical technology news, interview leaders within the field, and file dispatches from medical occasions from around the globe.

Exactly what do doctors want in the Surgeon General?

Dr. Jerome Adams may be the 20th U.S. Surgeon General.

Since 1871, choices general continues to be acknowledged as the official position when Dr. John Woodworth was hired the very first Supervising Surgeon from the national hospital system. The Marine Hospital was reorganized in to the national hospital system the last year.  On The month of january 4, 1889, Congress renamed the personnel that come with this office because the Commissioned Corps. The Corps started along military lines and initially contained only physicians. Wherever a necessity came about, these were mobilized to fight it.

Just before 1968, choices General was mind from the Public Health Service (PHS).  In 1968, President Lyndon B. Manley delegated down to the PHS to Assistant Secretary of Health insurance and abolished work from the Surgeon General. The positioning of the Surgeon General grew to become what principal deputy from the Assistant Secretary of Health insurance and was accountable for becoming an consultant on medical matters. Later, work from the Surgeon General was reestablished like a staff office inside the office from the Assistant Secretary of Health.

Initially, Dr. John Woodworth was given the job of repairing the Marine Hospital Service, that was inside a condition of disrepair and greatly over-crowded. He could rapidly lift a healthcare facility out of this decrepit condition and, with other people, created the united states Department of Health insurance and Human Services. Work also required part in addressing social problems that impacted health, especially before The First World War. President William Taft hired Rupert Blue to work who concerned themself with the truth that workers didn’t earn enough to consume in a healthy manner. Because the war intensified, he switched his focus to look after wounded veterans and so the Spanish flu if this hit.  Another surgeon general, Hugh S. Cummings, concerned themself using the risks of smoking cigarettes and leaded gasoline.

Possibly among the best-known Surgeon Generals was C. Everett Koop. He offered two terms under Taxation and through the onslaught from the AIDs epidemic. Because his superiors feared AIDs would become the greatest public health catastrophe from the 20th Century, he was made to operate in silence. It wasn’t until 1986 he was permitted to issue a Surgeon General’s statement on AIDS as well as in 1988, a congressional-mandated educational sales brochure around the disease was mailed to each house in america. Koop mentioned, “If ever there is an illness designed for a Surgeon General, it had been AIDS.”

The function from the office from the Surgeon General evolved greatly with time. It’s an office hired through the President of america and also the appointee serves a four-year term. Presently, it’s an office at work from the Assistant Secretary for Health in america Department of Health insurance and Human Services. The expectation from the Surgeon General is the fact that he/she’ll supply the best evidence-based information presently on improving health insurance and to prevent illness and injuries. Choices General is definitely a physician and it is given the job of to be the spokesperson for the federal government on all health-related issues. Furthermore, he/she advises obama and also the secretary of health insurance and human services on all public health manners. Finally, choices general serves on several boards and weighs in on health policy and national initiatives.

What if the new Surgeon General’s top priorities be?
Within the first week of August 2017, Dr. Jerome Adams was confirmed as Surgeon General as nominated by President Jesse Trump. By training, Dr. Adams is definitely an anesthesiologist who also offered because the Indiana condition health commissioner. He promised to tackle the US’s opioid epidemic stating, “The addictive qualities of prescription opioids is really a scourge in the usa and it should be stopped.”

As “The physician from the US” because the office continues to be known as for many years, physicians have strong opinions by what issues choices General should tackle. Inside a recent poll conducted by Platform Q Health,  roughly 45 percent of healthcare providers felt the Surgeon General’s main concern ought to be resourcing addiction recovery and mental health.

Resourcing addiction recovery and mental health
In america presently, greater than 6 from 10 drug overdose deaths involve an opioid. Actually, 91 Americans die each day because of opioids (including both prescription medicine and heroin). The CDC figured that the elevated quantity of opioid-related deaths in the last fifteen years is driven by prescriptions for opioid medications. Inside a New You are able to Occasions data analysis, drug overdose deaths rose 19 percent from 2015 through 2016. Preliminary analysis implies that rates are likely to jump even greater in 2017.

Previous Surgeon General Dr. Vivek Murthy issued a landmark study addressing substance addiction, the very first time in US history. In the 400-page report, he figured that 20.8 million Americans suffer an ingredient use disorder. However, only 10 % of those people get any treatment.

“Substance use disorders represent probably the most pressing public health crises in our time,Inches the report (by Murthy) states. “For way too lengthy, a lot of within our country have viewed addiction like a moral failing. This unfortunate stigma has produced an additional burden of shame which has made individuals with substance use disorders less inclined to come forward and seek help.”

Championing Evidence-Based Patient Education and Fighting Fake Medical News
Roughly 20 % of respondents within the PQ Health poll have the main concern ought to be fighting fake medical news and supplying evidence-based patient information. Presently, more people are searching to the web and social networking to locate medical information. A number of these sites are simply gimmicks to market products or push a particular agenda. There’s no regulation over who gives medical information and it doesn’t need to end up being evidence-based. Clearly, some standards have to be set to make sure people are being able to access probably the most up-to-date and accurate health information.

Promoting Antibiotic Stewardship
Roughly 18 percent of respondents felt promoting antibiotics ought to be a high priority from the office from the Surgeon General. The CDC reported that each year in america, roughly two million people become have contracted a bacteria that’s resistant against antibiotics. Greater than 23,000 individuals will die of those infections. And others die from problems that were complicated by antibiotic-resistant infections.

Many experts attribute an upswing of antibiotic potential to deal with the misuse and overuse of antibiotics. The rise of antibiotic resistance isn’t just within the U.S. however a global phenomenon that’s threatening our capability to fight microbial infections. Using antibiotics first began in 1928 using the discovery of Penicillin by Mister Alexander Fleming. Countless lives happen to be saved through their use ever since then. Regrettably, we view antibiotic potential to deal with virtually every known antibiotic. Actually, Fleming first elevated the warning concerning the overuse of antibiotics in 1945.

Antibiotics are actually a restricted resource, you will find presently less effective antibiotics readily available for certain health-care-connected infections than in the last decade, and the specter of antibiotic resistance is real.”  Boris D. Lushniak, MD, Miles per hour RADM, U.S. Public Health Service Acting Surgeon General

Reemphasizing Vaccinations
Roughly 17 % from the poll respondents felt that reemphasizing vaccines ought to be the main concern. In today’s world, we view the results from the anti-vaxxer propaganda and just how distributing myths/fake news can lead to harm when children don’t get the vaccines they require. Our previous Surgeon General Murthy placed significant focus on stopping illnesses and greatly encouraged individuals to receive vaccines. Actually, he met with Sesame Street icon, Elmo in March 2015 and filmed an open safety announcement around the safety and effectiveness of vaccines. He mentioned the web would be a tool that, while proficient at amplifying reliable information, also amplifies unsound information too, which makes it particularly challenging. Obviously, this problem is directly consistent with championing evidence-based patient education and fighting fake medical news.

The United States, along with the world, has become facing public health issues we have never faced before. We’ve technology that disseminates information rapidly and vastly. We currently be capable of achieve around the world to assist others. Contrarily, any mistakes could be a plague to the healthiness of others.

Choices General is within a distinctive position to advise leaders and also the public alike concerning the most pressing health problems in our occasions. While you can come with an opinion regarding the most threatening, possibly they all are essential and national strategies have to be in position to deal with each area within the lengthy term.

How one hospital reduced alarms without undermining patient safety

data, patient, medical records, health data, healthcare data

Keeping patient safety surface of thoughts are crucial, and vigilance is essential within the hospital atmosphere.

But intricately associated with safety concerns may be the hazard of alarm fatigue. Being uncovered to some large number of alarms can desensitize clinicians to alarms, therefore putting patient safety in danger.

The problem is an elaborate someone to solve, however a study printed in Biomedical Instrumentation & Technology examines one sort of solution.


The study, which would be a follow-as much as a preliminary pilot study, required place at Mount Carol, Nj-based Virtua Memorial Hospital. It incorporated 25 anti snoring patients within the hospital’s publish-anesthesia care unit.

“Patients undergo complex surgeries that need publish-operative discomfort control,” Dr. Leah Baron, the chair of Virtua’s department of anesthesiology, stated within an interview. “Although multi-modal discomfort management recently has acquired wide acceptance, opioids remain the premise of postoperative discomfort management for most of the surgical treatments. The discomfort relief isn’t without potential issues. Opioids have a lot of undesirable negative effects, including respiratory system depression.”

Due to stated potential respiratory system problems, these people are particularly significant to watch. But this is where the alarm fatigue is available in.

“The technology that’s said to be enhancing the nurses’ workflow is really distracting them from observing their sufferers directly,” Jeanne Venella, CNO of Milford, Connecticut-based Bernoulli Health, stated inside a phone interview.

John Zaleski, Bernoulli’s chief analytics officer, echoed individuals ideas. “Particularly in units that aren’t outfitted to handle alerts, you are able to rapidly inundate the concern staff with many different noise,” he stated throughout a phone interview. “These can result in noises that aren’t always clinically actionable.”

Baron, Venella and Zaleski are coauthors from the study.

To mitigate these complaints, Virtua partnered with Bernoulli Health insurance and implemented its Respiratory system Depression Safety Surveillance system, which offered being an alarm filter or “smart alarm” of sorts. It filtered out data from multiple medical devices and pinpointed clinically actionable occasions. On the top of this, the research discovered that it reduced the general quantity of alarms by 98 percent — without having to put patients’ safety in danger.

“Smart alarms remove the noise making us conscious of the worth,Inches Venella stated. Instead of overwhelming clinical staff having a high frequency of alarms, we’ve got the technology turns from the unnecessary notifications and heightens nurses’ awareness to when there’s really an issue.

With the study, Virtua discovered the need for education and mix-departmental support.

But it’s still a developing area.

“We many userful stuff here out of this study,” Baron stated. “A lot still must be done in this subject. With this particular exciting technology, we’re one step nearer to having the ability to bring safer choose to our patients along with a better work atmosphere to nurses and physicians taking care of these complex patients.”

Photo: nevarpp, Getty Images

The friendly skies felled HHS Secretary Tom Cost, so what’s next for healthcare policy?

U.S. Heath and Human Services Secretary Tom Cost participates within an event to advertise influenza vaccine in the National Press Club September 28, 2017 in Washington, Electricity. (Photo by Nick Somodevilla, Getty Images)

Health insurance and Human Services Secretary Tom Cost has resigned his publish within the wake from the scandal over his utilization of private jets and government planes towards the tune in excess of $a million for U.S. taxpayers since May, based on Politico.

The scandal is even more wealthy for men who supported $1 trillion in State medicaid programs spending cuts as area of the U.S. House of Representatives’ ACA repeal and replace bill. He’d contended in support of states using government funds to personalize their programs to match the requirements of their residents. Price’s resignation comes just like open enrollment is going to start, departing lots of questions in the wake in the fate of bundled payments to spread out enrollment along with other healthcare reform measures in the Affordable Care Act.

Politico acquired a duplicate of Price’s resignation letter which noted he regretted the scandal produced a distraction from important objectives like the damaged healthcare system, empowering patients, reducing regulatory burdens, health security, the opioids epidemic, serious mental illness and childhood weight problems.

In testimony before the Senate Finance Committee and the House Methods Committee over the summer time, Cost attempted to reason that his critique over federal health programs wasn’t that they are too costly or too underfunded. “The real issue is that they don’t work — they fail the people they should help,” Similar to Cost.

With Cost gone, his interim substitute is Health insurance and Human Services Deputy Secretary Don Wright and speculation turns to who’ll succeed him. The Hill noted that some possible candidates include Seema Verma, who manages the Centers for Medicare and State medicaid programs. Scott Gottlieb, the U.S. Fda Commissioner, is yet another name that’s been pointed out.

The departure leaves an issue mark over Price’s push to limit or reduce healthcare reforms from the Federal government. Under Cost, the Centers for Medicare and State medicaid programs cut bundled payment programs like the Cardiac Rehabilitation (CR) Incentive Payment Model and scaled back the excellent Take care of Joint Substitute program from 67 geographic regions to 34. Bundled payments are broadly considered like a necessary part of the shift from fee for plan to value-based care. In addition, there’s been concern over perceived tries to undermine promotion of Open Enrollment from cutting advertising to intends to shut lower the healthcare.gov industry for maintenance for 12 hrs each weekend except one this fall.

Given how popular Trump makes it to locate contradictions in the ever altering political stances, Cost on Cost is every bit amusing. Because of Shai Goldman at Plastic Valley Bank for unearthing this 2009 CNBC video of then Georgia Repetition Tom Cost wagging his proverbial finger at fellow Congressmen for his or her passion for private jets.

https://world wide web.youtube.com/watch?v=67XM3uFHjIo

2 contrasting medtech approaches to cope with chronic discomfort and steer clear of opioids

Because the nation battles the opioid crisis, medtech information mill counting on versions of the technology they hope creates a real dent in how chronic discomfort is treated and managed: neurostimulation.

On Monday, Medtronic announced that Food and drug administration has approved its Intellis implantable spinal-cord stimulation system to deal with chronic, intractable discomfort. The unit works together with the Samsung Universe Tab S2 interface and collects data twenty-four hours a day. The actual-time accessibility to data enables physicians to create modifications towards the therapy regimen.

“Chronic discomfort is difficult to manage. Getting real-time data can offer more details about patients’ quality of existence changes,” stated Dr. Lance Roy, discomfort medicine specialist at Duke College Clinic, inside a Medtronic news release. “This platform represents a welcome new choice for managing some types of chronic discomfort. New non-opioid treatments are essential because of the national crisis associated with opioid abuse.”

While Medtronic hopes the most recent, tiniest spinal-cord neurostimulator goes aways to supply an alternate, a much smaller sized clients are also making some headway to advertise adoption of their neurostimulation device.

SPR Therapeutics announced a week ago it has elevated a $25 million Series C round to grow the sales of their Food and drug administration-removed SPRINT wearable neurostimulation device.

The peripheral nerve stimulation system is made to treat chronic and acute discomfort after a health care provider prescribes it, the treatment can be carried out in your own home. Within an email forwarded with a representative, the founder, president and Chief executive officer of SPR Therapeutics challenged the traditional knowledge about neurostimulation and discomfort management as espoused by the kind of Medtronic.

“The prevailing knowledge in discomfort management and neurostimulation therapies for several years continues to be that stimulation should be provided chronically to supply lengthy-term discomfort relief.  Consequently, there’s been a proliferation of permanently implantable systems,” authored Maria Bennett.

But citing the instance of the patient who she stated was comfortable even 2 yrs following a treatment, Bennett described the treatments are just for two months or eight days then the leads are withdrawn.

The $25 million series C round originates from Frontcourt Ventures as well as an unnamed family office brought the round. Previous investors include Frontcourt along with other high-internet-worth individuals and family offices.

The cash will be employed to hire the Cleveland company’s first dedicated salesforce and clinical and research personnel, Bennett stated. Further, the cash will be employed to fund numerous studies which will test the unit for other kinds of discomfort including low back discomfort and discomfort after total knee replacements.

SPR Therapeutics has elevated greater than $60 million.

Food and drug administration permits marketing of mobile medical application for substance use disorder

Printed 15 September 2017

The United States Fda allowed marketing from the first mobile medical application to assist in treating substance use disorders (SUD).

The Reset application will probably be combined with outpatient therapy to deal with alcohol, cocaine, marijuana and stimulant SUDs. The applying isn’t supposed to have been accustomed to treat opioid dependence.

“This is a good example of how innovative digital technologies might help provide patients use of additional tools throughout their treatment,” stated Carlos Peña, Ph.D., M.S., director from the Division of Nerve and Physical Medicine Devices in FDA’s Center for Devices and Radiological Health.

“More therapy tools means a larger possibility to help to improve outcomes, including abstinence, for patients with substance use disorder.”

Based on the Drug Abuse and Mental Health Services Administration, SUD takes place when a person’s recurrent utilization of alcohol and/or drugs causes clinically and functionally significant impairment, for example health issues, disability, and failure to satisfy major responsibilities at the office, school or home.

Based on the Diagnostic and Record Manual of Mental Disorders, Fifth Edition, an analysis of substance use disorder is dependant on proof of impaired control, social impairment, dangerous use and medicinal criteria.

The Reset system is a mobile medical application system that contains someone application and clinician dashboard. The unit delivers cognitive behavior therapy to patients to educate the consumer skills that assisted in the management of SUD and usually are meant to increase abstinence from drug abuse while increasing retention in outpatient therapy programs.

The machine will probably be used along with outpatient therapy and additionally to some contingency management system, a broadly-used program for the treatment of SUD that utilizes a number of incentives to reward patients for adherence for their treatment plan.

The Food and drug administration reviewed data from the multi-site, unblinded 12-week medical trial of 399 patients who received either standard treatment or standard treatment with the help of a desktop-based form of Reset that could be utilized in the clinic or in your own home.

The information demonstrated a statistically significant rise in adherence to abstinence for that patients with alcohol, cocaine, marijuana and stimulant SUD in individuals who used Reset, 40.3 %, when compared to patients who didn’t, 17.6 %. The medical trial didn’t demonstrate the potency of while using Reset device in patients reporting opioids his or her substance of abuse.

The Reset system is indicated like a prescription-only adjunct strategy to patients with SUD who aren’t presently on opioid substitute therapy, who don’t abuse alcohol exclusively, or whose primary substance of abuse isn’t opioids.

Data in the studies didn’t indicate any negative effects connected using the device. The adverse occasions evaluated were usual for patients with SUD, including coronary disease, gastrointestinal occasions, depression, mania, suicidal behavior, suicidal ideation and attempts.

The Reset device was reviewed with the de novo premarket review path, a regulatory path for many low- to moderate-risk devices which are novel as well as for which there’s no legally marketed predicate device that the unit can claim substantial equivalence.

The Food and drug administration allowed marketing from the Reset device to Pear Therapeutics

Source: Company Pr Release

SPR Therapeutics safeguards funding to commercialise Sprint PNS system

Printed 14 September 2017

SPR Therapeutics, a personal medical device company which has created a novel neurostimulation technology for chronic and acute discomfort, has announced the conclusion of $25m in series C financing.

An investment will be employed to commercialize its Food and drug administration-removed Sprint peripheral nerve stimulation (PNS) system and also to fund additional research across multiple indications including publish-surgical acute discomfort and chronic mid back discomfort.

 A prominent family office and Frontcourt Ventures brought the round. 

The funding comes at any given time when opioid use, abuse and addiction are fueling a devastating nationwide epidemic with 91 Americans dying every single day from your opioid overdose.  The SPRINT PNS System provides a non-narcotic solution for that relief of chronic and acute discomfort. 

The treatment utilizes a threadlike wire placed with the skin, which connects to some wearable stimulator to activate target nerve fibers to attain discomfort relief.  It delivers sustained, significant discomfort relief without opioids, permanent implants or tissue destruction. 

“The opioid crisis is personal to all of us at SPR, as the house condition of Ohio has among the greatest drug overdose dying rates in america,Inches stated Maria Bennett, Chief executive officer, President and founding father of SPR.  “This funding will let us offer SPRINT, a effective and safe discomfort-relief therapy, to more discomfort sufferers.” 

The organization also announced the appointment of Nick Valeriani towards the SPR board of company directors.  Mr. Valeriani is really a distinguished and experienced healthcare leader getting formerly offered because the Chief executive officer of West Health insurance and just before that, spent 34 years with Manley & Manley serving on its Executive Committee as worldwide chairman of medical devices & diagnostics, and v . p . from the Office of Strategy & Growth.

“Nick is a vital accessory for the SPR Board because he has deep knowledge of effectively commercializing numerous, game-altering therapies.  He’s a visionary in the area of healthcare and it has frequently been in front of the curve in identifying global healthcare trends,” stated Bennett.

“The SPR Therapeutics leadership team is composed of recognized experts within the neuromodulation and discomfort management industries,” stated Mr. Valeriani.  “I am excited to aid Maria and her gifted team because they get this to innovative, groundbreaking technology commercially accessible to huge numbers of people seeking non-opioid relief of chronic and acute discomfort.”

Additionally to prior equity financing of roughly $ten million, SPR has gotten nearly $23 million up to now in non-dilutive funding from sources such as the U.S. Dod and also the National Institutes of Health.

Source: Company Pr Release

Zynex Announces Efforts to deal with the Opioid Crisis

LONE TREE, Colo., Sept. 6, 2017 /PRNewswire/ — Zynex, Corporation. (OTCQB: ZYXI), a cutting-edge medical technology company focusing on the manufacture and purchase of non-invasive medical devices for discomfort management, stroke rehabilitation, cardiac monitoring and nerve diagnostics, today announced an attempt to deal with the nationwide opioid crisis.

Recently, obama declared the opioid epidemic a nationwide emergency. Patients struggling with chronic or debilitation discomfort are frequently prescribed opioids like a first type of defense for his or her discomfort and also the effects of the are devastating:

  • Dying rates because of opioid abuse have elevated substantially, with nearly 100 Americans dying every day.
  • More and more people in america die from drug overdoses than vehicle accidents and nearly 2/3 of those were associated with opioid use.
  • The United States labor pressure is feeling the outcome too. Almost 50% from the prime-age male labor pressure take presctiption daily doses of discomfort medication while at the office, negatively impacting worker productivity and growing the quantity companies invest in healthcare. 
  • Many trying to get tasks are not able to pass through drug tests, contributing to the united states labor shortage. Additionally, personnel are falling from the employment market because of seeking strategy to opioid abuse.
  • Opioid abuse has turned into a $80 billion issue in the US, which is not isolated to the particular population. This crisis affects men in addition to women, of races, across all socio-economic levels.

Zynex’s Founder and Chief executive officer, Thomas Sandgaard commented: “We strongly believe Zynex’s prescription-strength e-stim solution, hot/cold therapy, and spine bracing lines should be utilized for the very first type of defense instead of medication because of so many gloomy effects. We all know that people are less inclined to start lower the road toward reliance upon opioids when drug-free options are for sale to them.  Our type of drug-free products could be prescribed by health care professionals through our exclusive EZ-Prescribe program. The program makes prescribing our products as simple as prescribing dental medications and it is open to any specialist nationwide. Our NexWave device provides prescription strength discomfort relief without negative effects.

“We’re centered on growing use of our drug-free solutions by expanding our sales pressure presence and growing understanding of our EZ-Prescribe program to practitioners nationwide, including rural areas. We are launching more initiatives to boost awareness about our solutions while increasing prescription use of our products.”

About Zynex 
Zynex, founded in 1996, markets and sells its very own style of electrotherapy medical devices employed for discomfort management and rehabilitation and also the company’s proprietary NeuroMove device made to help recovery of stroke and spinal-cord injuries patients. Zynex can also be creating a new bloodstream volume monitor to be used in hospitals and surgery centers.  To acquire more information, check out: Zynex.com.

Safe Harbor Statement 
Certain statements within this release are “forward-searching” and therefore are susceptible to numerous risks and uncertainties. Actual results can vary considerably in the results expressed or implied such statements. Factors that may cause actual leads to materially vary from forward-searching statements include, but aren’t restricted to, the necessity to obtain additional capital or augment our liquidity to be able to continue our business, the prosperity of our worldwide expansion efforts, our capability to engage additional sales representatives as well as their success, the necessity to obtain Food and drug administration clearance and CE marking of recent products, the acceptance of recent products in addition to existing products by doctors and hospitals, bigger competitors with greater financial sources, the necessity to keep pace with technological changes, our reliance on the reimbursement from insurance providers for products offered or rented to the customers, acceptance in our products by medical health insurance providers, our reliance on 3rd party manufacturers to create our goods promptly and also to our specifications, implementation in our sales strategy together with a strong network marketing pressure, the uncertain results of pending material litigation, our capability to up-list to some bigger exchange along with other risks described within our filings using the Registration such as the “RisksInch portion of our Annual Set of Form 10-K for that year ended December 31, 2016 in addition to Forms 10-Q, 8-K and eight-K/A, press announcements and also the Company’s website.

Contact: Zynex, Corporation.  (303) 703-4906 
Investor Relations Contact:
Amato And Partners, LLC
Investor Relations Counsel
[email protected]

View original quite happy with multimedia:http://world wide web.prnewswire.com/news-releases/zynex-announces-efforts-to-address-the-opioid-crisis-300514445.html


Related Links


MMJ Labs Awarded New Patent Associated with Their Awesome-Pulse™ Technology

ATLANTA, August. 23, 2017 /PRNewswire/ — MMJ Labs, LLC, a worldwide leader in noninvasive discomfort relief medical devices, announced today it’s been awarded another patent in the U . s . States Patent and Trademark Office associated with their novel discomfort management platform, US Patent No. 9,358,152.

MMJ Labs expanded patent portfolio is based on the extensive clinical research demonstrating synergistic results of thermal and vibrational stimulation. VibraCool® vibrational cryotherapy system is getting used not just for muscle recovery however for chronic discomfort relief and also to avoid opioids. The study underpinning the patent filings shows vibration speeds repair in a cellular level.

Awesome-Pulse™ technology, coded in spend funding in the NIH Small Company Innovative Research program, combines high frequency, low amplitude vibration along with a thermal treatment pack that may add cooling to disrupt nerve impulses of discomfort. Additional patent applications are pending with this technology.

“We’re thrilled concerning the profound effects our straightforward multiple-use technology might have on reducing discomfort medication dependence,” stated Amy Baxter MD, founder and Chief executive officer of MMJ Labs. “Comprehending the multiple ways in which vibration and thermal sources can interact straight to alter nerve signals is a big advance for publish-surgical discomfort management, sports recovery, and chronic discomfort.” Baxter notes supporting research by Lam et al., Fillipi et al., Peer et al., and Imtiyaz et al., amongst others.

To understand more about VibraCool®, visit world wide web.VibraCool.com, or even the needle discomfort reduction products Buzzy® and DistrACTION® cards at world wide web.buzzyhelps.com. Participate in conversations about discomfort relief with VibraCool on Facebook, Twitter and Instagram.

About MMJ Labs, LLC

MMJ Labs, LLC, located in Atlanta, Georgia, is really a lady-owned small company (WOSB) researching, developing, and delivering quality discomfort relief medical devices to hospitals and patients worldwide. MMJ Labs products have unique Food and drug administration product codes as Class I medical devices, with CE clearance and acceptance by ANVISA, KFDA, and Australia and Nz health boards. To learn more, see world wide web.MMJLabs.com.

Press Contact

Megabites Treat
[email protected]

Dr. Amy Baxter
[email protected]

Related Links

VibraCool Website